Neurotech, Neuromodulation, Alzheimers.
the same conclusion. Treatments aimed at preventing or reducing beta-amyloids thought to cause AD have been studied for going on 20 years. More recently, in 2019, Nature published a review of four different anti-amyloid antibody trials that all failed to show effectiveness. Also, in 2019 drug